ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 337

$571K Total Retail Price of All Prescriptions

Rank: 53 out of 337

687 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 687 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 687 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 11,182 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METOPROLOL TARTRATE 611 523 1 6
LOSARTAN POTASSIUM 589 553 2 15
PRAVASTATIN SODIUM 559 428 3 14
LISINOPRIL 526 431 4 2
AMLODIPINE BESYLATE 519 499 5 3
ATENOLOL 516 482 6 10
LEVOTHYROXINE SODIUM 493 349 7 5
OMEPRAZOLE 417 390 8 4
FUROSEMIDE 349 301 9 8
HYDROCHLOROTHIAZIDE 279 269 10 9
ATORVASTATIN CALCIUM 275 242 11 7
SIMVASTATIN 256 233 12 1
METOPROLOL SUCCINATE 247 239 13 21
CHLORHEXIDINE GLUCONATE 226 61 14 183
TRIAMTERENE-HCTZ 208 190 15 39
METFORMIN HCL 193 171 16 12
WARFARIN SODIUM 180 174 17 11
CITALOPRAM HBR 167 127 18 17
RANITIDINE HCL 151 107 19 30
GLYBURIDE 149 145 R 20 53
METFORMIN HCL ER 131 121 21 52
PAROXETINE HCL 124 121 22 46
CLOPIDOGREL 121 121 23 42
CRESTOR 120 120 24 29
SERTRALINE HCL 118 76 25 18
TRAZODONE HCL 117 89 26 16
RISPERIDONE 108 19 27 72
GABAPENTIN 105 82 28 20
LACTULOSE 100 0 29 105
DIOVAN 97 85 30 26
PANTOPRAZOLE SODIUM 95 73 31 36
ENALAPRIL MALEATE 94 91 32 37
SYNTHROID 93 93 33 41
HYDROCODONE-ACETAMINOPHEN 92 75 S3 34 13
MIRTAZAPINE 92 25 34 27
LIPITOR 89 83 36 33
ZOLPIDEM TARTRATE 87 75 37 23
TAMSULOSIN HCL 84 77 38 25
POLYETHYLENE GLYCOL 3350 84 29 38 47
PLAVIX 82 82 40 74
BENZTROPINE MESYLATE 82 41 R 40 172
PROPRANOLOL HCL 81 77 42 121
DIGOXIN 80 80 43 58
LEVOXYL 79 75 44 90
POTASSIUM CHLORIDE 77 75 45 62
ALLOPURINOL 76 75 46 28
BUSPIRONE HCL 73 0 47 129
FLUTICASONE PROPIONATE 73 48 47 34
LORAZEPAM 71 71 49 119
THIORIDAZINE HCL 70 14 R 50 291
GLIMEPIRIDE 70 51 50 55
CARBAMAZEPINE 67 0 52 207
LOSARTAN-HYDROCHLOROTHIAZIDE 67 55 52 60
DILTIAZEM 24HR ER 67 67 52 76
KLOR-CON M20 66 66 55 65
PREDNISONE 65 63 56 40
FLUOXETINE HCL 64 41 57 57
DIVALPROEX SODIUM 64 12 57 101
CELEBREX 63 61 59 116
LANTUS 59 52 60 49
SPIRIVA 59 55 60 43
ISOSORBIDE MONONITRATE ER 56 56 62 70
JANUVIA 54 54 63 81
IBUPROFEN 52 37 64 64
COMBIVENT 51 41 65 126
NIFEDIPINE ER 50 45 66 111
FINASTERIDE 50 50 66 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.